Silencing of the long non-coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial-mesenchymal transition.
In conclusion, the present study suggested that GHET1 may be considered a therapeutic target for the treatment or prevention of RCC.
PMID: 30867747 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Gastric (Stomach) Cancer | Gastroenterology | Kidney Cancer | Renal Cell Carcinoma | Study